LOS ANGELES, May 28, 2018 /PRNewswire-PRWeb/ --áJen Wilding, a Los Angeles-based hypnosis
"The idea originally came from a client's request," Jen remarked when asked about what inspired the creation of the Mental Marijuana audios. "The client, a young woman, had been using marijuana successfully as a sleep aid and felt too dependent on it to relieve her chronic insomnia. She was planning to spend a week at her parents' house and, since they didn't live in a city that supported legal cannabis use, she wished to recreate the physical and mental effects in a drug-free way to ensure continued access to good quality sleep at night. She was pleasantly surprised to discover that it is possible to use a hypnosis process for both deep relaxation and to generate that beautiful feeling of positive elation (or high) many people seek with medicinal plant use."
The Mental Marijuana albums consist of spoken-word guided hypnosis accompanied by soothing background music and are currently available as digital downloads via online music marketplaces such as iTunes, Amazon, and CDBaby. The albums include a brief introduction track, in addition to the primary meditation track that runs approximately twenty-two minutes in duration. The audios are intended for individual listening, with headphone use and retail pricing begins at $9.45 per album. For more information on the Mental Marijuana Meditation audio recordings, visit http://subconsciousedge.com
About Jen Wilding
Jen Wilding is a personal development coach, book author and hypnosis practitioner based in Los Angeles. In addition to Mental Marijuana meditations, she has also released Hypnosis for Healthy Weight Loss and Hypnosis for Relief of Teeth Grinding albums as part of her Subconscious Edge Series audio collection.
SOURCE Jen Wilding
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All